232.47
-4.62
(-1.95%)
As of January 7 at 11:53:35 AM GMT-3. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 31 | 30 | 38 | 41 |
Avg. Estimate | 14.6B | 14.72B | 61.16B | 70.4B |
Low Estimate | 13.92B | 13.92B | 54.21B | 62.31B |
High Estimate | 14.87B | 15.95B | 64.34B | 79.79B |
Year Ago Sales | 11.96B | 12.49B | 51.57B | 61.16B |
Sales Growth (year/est) | 22.06% | 17.85% | 18.58% | 15.12% |
EPS Trend
Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
AVGO.SN | -- | -- | -- | -- |
S&P 500 | 8.59% | 11.42% | 13.98% | 13.43% |
Upgrades & Downgrades
Maintains | Mizuho: Outperform to Outperform | 1/10/2025 |
Maintains | Morgan Stanley: Overweight to Overweight | 12/20/2024 |
Maintains | Barclays: Overweight to Overweight | 12/16/2024 |
Maintains | JP Morgan: Overweight to Overweight | 12/13/2024 |
Maintains | Jefferies: Buy to Buy | 12/13/2024 |
Reiterates | Benchmark: Buy to Buy | 12/13/2024 |